Fluid Imaging Technologies (Scarborough, ME), and the University of Colorado Boulder (Boulder, CO) have entered into an exclusive agreement to conduct primary laboratory research aimed at determining whether the university’s artificial intelligence (AI) software can detect bloodborne bacteria and identify the species from images collected using the company’s FlowCam Nano particle imaging and analysis system. Read more
Study to investigate use of artificial intelligence for identifying bloodborne bacteria
Related Posts
Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming
Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...
UNE retains R2 Research status, reinforcing leadership in scientific advancement
The University of New England has retained its status as one of the country’s leading research universities with the recent release...
Maine college students investigate health effects of forever chemicals
Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...